Filing Details

Accession Number:
0000899243-19-004561
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-02-22 16:36:01
Reporting Period:
2019-02-19
Accepted Time:
2019-02-22 16:36:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1346302 Xeris Pharmaceuticals Inc XERS Pharmaceutical Preparations (2834) 203352427
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1652410 Beth Hecht C/O Xeris Pharmaceuticals, Inc.
180 N. Lasalle Street, Suite 1810
Chicago IL 60601
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-02-19 2,500 $10.00 2,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Ms. Hecht purchased shares of common stock from the underwriters in a public offering pursuant to the registrant's Registration Statement on Form S-1 (File No. 333-229665, completed on February 19, 2019). The shares of common stock were purchased at the public offering price.